Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian R Edlin

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Nature|May 27, 2011
Perspective: test and treat this silent killerBrian R Edlin
The Lancet. Infectious Diseases|July 17, 2016
Access to treatment for hepatitis C virus infection: time to put patients firstBrian R Edlin
Hepatology (Baltimore, Md.)|December 15, 2012
Hepatitis C screening: getting it rightBrian R Edlin
Hepatology (Baltimore, Md.)|October 31, 2002
Prevention and treatment of hepatitis C in injection drug usersBrian R Edlin
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2006
Injection drug users: the overlooked core of the hepatitis C epidemicBrian R Edlin, Michael R Carden
The American Journal of Gastroenterology|September 1, 2005
Written in response to Scott LD: treating hepatitis C in active injection drug usersBrian R Edlin, Michael R Carden
Antiviral Research|August 12, 2014
Can hepatitis C be eradicated in the United States?Brian R Edlin, Emily R Winkelstein
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2004
Infrequent reinfection after successful treatment for hepatitis C virus infection in injection drug usersMarkus Backmund, Kirsten Meyer, Brian R Edlin
Current Hepatitis Reports|June 27, 2013
Managing Hepatitis C in Users of Illicit DrugsBrian R Edlin, Michael R Carden, Stephen J Ferrando
Journal of Addictive Diseases|February 7, 2009
The risk of emergency room treatment due to overdose in injection drug usersMarkus Backmund, Christian Schuetz, Kirsten Meyer, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Nature|May 27, 2011
Perspective: test and treat this silent killerBrian R Edlin
The Lancet. Infectious Diseases|July 17, 2016
Access to treatment for hepatitis C virus infection: time to put patients firstBrian R Edlin
Hepatology (Baltimore, Md.)|December 15, 2012
Hepatitis C screening: getting it rightBrian R Edlin
Hepatology (Baltimore, Md.)|October 31, 2002
Prevention and treatment of hepatitis C in injection drug usersBrian R Edlin
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2006
Injection drug users: the overlooked core of the hepatitis C epidemicBrian R Edlin, Michael R Carden
The American Journal of Gastroenterology|September 1, 2005
Written in response to Scott LD: treating hepatitis C in active injection drug usersBrian R Edlin, Michael R Carden
Antiviral Research|August 12, 2014
Can hepatitis C be eradicated in the United States?Brian R Edlin, Emily R Winkelstein
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2004
Infrequent reinfection after successful treatment for hepatitis C virus infection in injection drug usersMarkus Backmund, Kirsten Meyer, Brian R Edlin
Current Hepatitis Reports|June 27, 2013
Managing Hepatitis C in Users of Illicit DrugsBrian R Edlin, Michael R Carden, Stephen J Ferrando
Journal of Addictive Diseases|February 7, 2009
The risk of emergency room treatment due to overdose in injection drug usersMarkus Backmund, Christian Schuetz, Kirsten Meyer, et al.
Pageof 8